Ken Griffin started to build up the position in Millendo Therapeutics in Q1 2020 and continued to invest until Q3 2020. Since then they sold 794 Thousand shares. The investor completely sold their stake between Q1 2021 and Q2 2021.
Avg closing price
Price range
Sold -401 Thousand shares
Q2 2021
Avg closing price
$1.17
Price range
$0.93
-
$1.53
Sold 49.5% shares (-393 Thousand shares)
Q1 2021
Avg closing price
$2.07
Price range
$1.20
-
$2.73
Increased shares by 24.8% (+158 Thousand shares)
Q3 2020
Avg closing price
$1.74
Price range
$1.51
-
$2.02
Increased shares by 69.7% (+261 Thousand shares)
Q2 2020